We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LILA icon
3451
Liberty Latin America Class A
LILA
$1.68B
$31K ﹤0.01%
3,296
-3,675
-53% -$34.9K
MFC icon
3452
Manulife Financial
MFC
$72.7B
$31K ﹤0.01%
1,595
-959
-38% -$20.1K
MTN icon
3453
Vail Resorts
MTN
$5.26B
$31K ﹤0.01%
99
-504
-84% -$161K
NCTY
3454
The9 Ltd
NCTY
$63.7M
$31K ﹤0.01%
214
+203
+1,845% +$36.8K
NTST
3455
NETSTREIT Corp
NTST
$2.02B
$31K ﹤0.01%
1,339
-850
-39% -$18.6K
PACK icon
3456
Ranpak Holdings
PACK
$461M
$31K ﹤0.01%
1,227
-1,144
-48% -$24K
PANL icon
3457
Pangaea Logistics
PANL
$452M
$31K ﹤0.01%
6,147
+2,688
+78% +$10.4K
PRLD icon
3458
Prelude Therapeutics
PRLD
$424M
$31K ﹤0.01%
1,065
-1,740
-62% -$62K
RKT icon
3459
Rocket Companies
RKT
$40.5B
$31K ﹤0.01%
1,608
-111,531
-99% -$2.26M
RMTI icon
3460
Rockwell Medical
RMTI
$27.9M
$31K ﹤0.01%
306
-291
-49% -$30K
SLDB icon
3461
Solid Biosciences
SLDB
$949M
$31K ﹤0.01%
572
-1,726
-75% -$114K
SNEX icon
3462
StoneX
SNEX
$7.96B
$31K ﹤0.01%
2,567
-3,255
-56% -$42.1K
SPWH icon
3463
Sportsman's Warehouse
SPWH
$46.8M
$31K ﹤0.01%
1,768
-13,489
-88% -$239K
TRC icon
3464
Tejon Ranch
TRC
$447M
$31K ﹤0.01%
2,041
-857
-30% -$13.3K
TRNS icon
3465
Transcat
TRNS
$893M
$31K ﹤0.01%
544
-498
-48% -$25.9K
VCTR icon
3466
Victory Capital Holdings
VCTR
$6.99B
$31K ﹤0.01%
963
+475
+97% +$13.9K
VGLT icon
3467
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
$31K ﹤0.01%
+355
New +$30.2K
WOW
3468
DELISTED
WideOpenWest
WOW
$31K ﹤0.01%
1,486
-6,936
-82% -$109K
SBT
3469
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$31K ﹤0.01%
6,879
+5,108
+288% +$24.8K
AWH
3470
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$31K ﹤0.01%
377
-36
-9% -$3.09K
SIEN
3471
DELISTED
Sientra, Inc.
SIEN
$31K ﹤0.01%
390
-1,206
-76% -$85.7K
HARP
3472
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$31K ﹤0.01%
222
+126
+131% +$24K
VLDR
3473
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$31K ﹤0.01%
+2,924
New +$34.5K
GIG
3474
DELISTED
GigCapital4, Inc. Common stock
GIG
$31K ﹤0.01%
+3,167
New +$30.9K
ALGS icon
3475
Aligos Therapeutics
ALGS
$45.5M
$30K ﹤0.01%
59
+27
+84% +$17.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.